Andover, MA — Navidea Biopharmaceuticals, Inc., a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, opened its new business and commercialization facility in Andover, with an official ribbon cutting ceremony attended by Massachusetts Governor Deval Patrick, representatives from the state’s life sciences and biotechnology industry associations and economic development agencies, and local officials. Navidea’s corporate headquarters, with clinical, manufacturing, regulatory and administration functions, are in Dublin, Ohio.
The Navidea event is part of a series of Massachusetts life sciences growth announcements taking place in the days prior to the BIO International Convention, which opened June 18th at the Massachusetts Convention & Exhibition Center in Boston. The Convention provided state and industry leaders an opportunity to showcase Massachusetts as a global leader, and a great place to do business for life sciences companies.
Navidea’s new facility, located in the New England Business Center in Andover, will serve as the business development office and the commercialization center for the commercial launch of the Company’s lead radiopharmaceutical product, Lymphoseek®, anticipated later this year. Lymphoseek is a proprietary lymph node targeting agent intended for use in intraoperative lymphatic mapping procedures conducted by oncology surgeons. Navidea currently has 12 employees and consultants in the Andover office with room for further expansion.
Navidea to Open New Facility Mass
Andover, MA — Navidea Biopharmaceuticals, Inc., a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, opened its new business and commercialization facility in Andover, with an official ribbon cutting ceremony attended by Massachusetts Governor Deval Patrick, representatives from the state’s life sciences and biotechnology industry associations and economic development agencies, and local officials.